These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 16894535)

  • 41. Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
    Viola-Villegas NT; Sevak KK; Carlin SD; Doran MG; Evans HW; Bartlett DW; Wu AM; Lewis JS
    Mol Pharm; 2014 Nov; 11(11):3965-73. PubMed ID: 24779727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
    Wang X; Ma D; Olson WC; Heston WD
    Mol Cancer Ther; 2011 Sep; 10(9):1728-39. PubMed ID: 21750220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA.
    Psimadas D; Valotassiou V; Alexiou S; Tsougos I; Georgoulias P
    Cancer Invest; 2018 Feb; 36(2):118-128. PubMed ID: 29393702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles.
    Mirochnik Y; Rubenstein M; Guinan P
    J Drug Target; 2007 Jun; 15(5):342-50. PubMed ID: 17541843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.
    Wolf P; Gierschner D; Bühler P; Wetterauer U; Elsässer-Beile U
    Cancer Immunol Immunother; 2006 Nov; 55(11):1367-73. PubMed ID: 16547705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody.
    Ikegami S; Yamakami K; Ono T; Sato M; Suzuki S; Yoshimura I; Asano T; Hayakawa M; Tadakuma T
    Hum Gene Ther; 2006 Oct; 17(10):997-1005. PubMed ID: 17032155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
    Liu H; Rajasekaran AK; Moy P; Xia Y; Kim S; Navarro V; Rahmati R; Bander NH
    Cancer Res; 1998 Sep; 58(18):4055-60. PubMed ID: 9751609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vector.
    Kuratsukuri K; Wang CY; Sone T; Nishisaka N; Jones RF; Haas GP
    Eur Urol; 2002 Jul; 42(1):67-73. PubMed ID: 12121733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen.
    Frigerio B; Benigni F; Luison E; Seregni E; Pascali C; Fracasso G; Morlino S; Valdagni R; Mezzanzanica D; Canevari S; Figini M
    Immunol Lett; 2015 Nov; 168(1):105-10. PubMed ID: 26404855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
    Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
    J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical nature and mapping of PSMA epitopes recognized by human antibodies induced after immunization with gene-based vaccines.
    Todorova K; Zoubak S; Mincheff M; Kyurkchiev S
    Anticancer Res; 2005; 25(6C):4727-32. PubMed ID: 16334167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded.
    Todorova K; Ignatova I; Tchakarov S; Altankova I; Zoubak S; Kyurkchiev S; Mincheff M
    Cancer Immun; 2005 Jan; 5():1. PubMed ID: 15641767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells.
    Zare H; Rajabibazl M; Rasooli I; Ebrahimizadeh W; Bakherad H; Ardakani LS; Gargari SL
    Int J Biol Markers; 2014 Jun; 29(2):e169-79. PubMed ID: 24425321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.
    Liu H; Moy P; Kim S; Xia Y; Rajasekaran A; Navarro V; Knudsen B; Bander NH
    Cancer Res; 1997 Sep; 57(17):3629-34. PubMed ID: 9288760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
    Chang SS; Reuter VE; Heston WD; Gaudin PB
    Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
    Gregor PD; Wolchok JD; Turaga V; Latouche JB; Sadelain M; Bacich D; Heston WD; Houghton AN; Scher HI
    Int J Cancer; 2005 Sep; 116(3):415-21. PubMed ID: 15800947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.
    Baiz D; Hassan S; Choi YA; Flores A; Karpova Y; Yancey D; Pullikuth A; Sui G; Sadelain M; Debinski W; Kulik G
    Neoplasia; 2013 Oct; 15(10):1172-83. PubMed ID: 24204196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
    Kraaij R; van Rijswijk AL; Oomen MH; Haisma HJ; Bangma CH
    Prostate; 2005 Feb; 62(3):253-9. PubMed ID: 15389777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.